"The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces the approval of the Russian Sputnik V vaccine against coronavirus in Democratic Socialist Republic of Sri Lanka. Sputnik V has been registered under the emergency use authorization procedure," RDIF said in a statement.
The Russian vaccine has now been approved for emergency use in 43 countries across the world.
Developed by the Gamaleya Research Institute of Epidemiology and Microbiology, Sputnik V was the world's first officially-registered vaccine against COVID-19.
